期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

分化型甲状腺癌促甲状腺素抑制治疗策略及进展 被引量：4

原文传递
导出
摘要 甲状腺癌是最常见的内分泌系统恶性肿瘤，分化型甲状腺癌包括乳头状癌和滤泡癌，占所有甲状腺癌的90％以上，且预后很好。促甲状腺素（thyrotropinTSH）抑制治疗是分化型甲状腺癌的重要治疗手段。尽管TSH抑制治疗的作用已受到公认，但随着研究的进展，TSH抑制治疗的策略逐渐发生改变。本综述主要总结了分化型甲状腺癌TSH抑制治疗的策略和进展。
作者 王佳峰 葛明华
机构地区 浙江省肿瘤医院头颈外科
出处 《国际耳鼻咽喉头颈外科杂志》 2012年第5期288-291,共4页 International Journal of Otolaryngology-Head and Neck Surgery
关键词 甲状腺肿瘤(Thyroid Neoplasms) 促甲状腺素(Thyrotropin)
分类号 R736.1 [医药卫生—肿瘤]
  • 相关文献

参考文献25

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin, 2008,58 (2):71-96.
  • 2Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19 (11):1167-1214.
  • 3Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol,2006, 154 (6):787-803.
  • 4Heemstra KA, Liu YY, Stokkel M, et al. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma. Clin Endocrinol (Oxf), 2007, 66 (1):58-64.
  • 5Jonklaas J, Sarlis NJ, Litofsky D, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid, 2006,16 (12):1229-1242.
  • 6Brabant G. Thyrotropin suppressive therapy in thyroid carcinoma: what are the targets? J Clin Endocrinol Metab, 2008,93 (4): 1167-1169.
  • 7Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am JMed, 1994,97 (5):418-428.
  • 8Pujol P, Daures JP, Nsakala N, et al. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab, 1996,81 (12):4318-4323.
  • 9McGriff NJ, Csako G, Gourgiotis L, et al. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med, 2002, 34 (7-8):554-564.
  • 10Cooper DS, Specker B, Ho M, et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid, 1998, 8 (9):737-744.

同被引文献49

  • 1邢兰兰,陈松,李亚明.分化型甲状腺癌促甲状腺激素抑制治疗的现状及进展[J].中华临床医师杂志（电子版）,2012,6(20):159-160. 被引量：17
  • 2唐平章.呼唤甲状腺肿瘤治疗的规范化[J].中华耳鼻咽喉头颈外科杂志,2006,41(6):401-402. 被引量：8
  • 3Tapscott WJ. A brief history of thyroid surgery. Curr Surg, 2001,8(5) :464466.
  • 4Cramer JD, Fu P, Harth KC, et al. Analysis of the risingincidence of thyroid cancer using the Surveillance, Epidemiologyand End Results national cancer data registry. Surgery, 2010,148(6) :1147-1152.
  • 5American Thyroid Association ( AT A ) Guidelines Taskforce onThyroid Nodules and Differentiated Thyroid Cancer, Cooper DS,Doherty GM, et al. Revised American Thyroid Associationmanagement guidelines for patients with thyroid nodules anddifferentiated thyroid cancer. Thyroid, 2009, 19(11) :1167-1214.
  • 6Jonklaas J, Sarlis NJ, Litofsky D, et al. Outcomes of patients withdifferentiated thyroid carcinoma following initial therapy. Thyroid,2006,16(12) :1229-1242.
  • 7Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgeryaffects survival for papillary thyroid cancer. Ann Surg,2007,246(3):375-381.
  • 8Pattou F, Combemale F, Fabre S, et al. Hypocalcemia followingthyroid surgery : incidence and prediction of outcome. World JSurg, 1998, 22(7) :718-724.
  • 9Asari R, Passler C, Kaczirek K, et al. Hypoparathyroidism aftertotal thyroidectomy : a prospective study. Arch Surg, 2008 , 143(2):132-137.
  • 10Boostrom S,Richards ML. Total thyroidectomy is the preferredtreatment for patients with Graves' disease and a thyroid nodule.Otolaryngol Head Neck Surg, 2007, 136(2) :278-281.

引证文献4

二级引证文献60

国际耳鼻咽喉头颈外科杂志
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部